T1	Disorder 0 14	Rhabdomyolysis
N1 	Reference T1 UMLS:C0035410	Rhabdomyolysis
T2	Pharmacological_substance 31 43	atorvastatin
N1000 	Reference T2 MeSH:D000069059	atorvastatin
T3	Pharmacological_substance 48 57	diltiazem
N1001 	Reference T3 MeSH:D004110	diltiazem
T4	Disorder 79 93	rhabdomyolysis
N2 	Reference T4 UMLS:C0035410	rhabdomyolysis
T5	Disorder 104 113	hepatitis
N3 	Reference T5 UMLS:C0019158	hepatitis
T6	Pharmacological_substance 154 166	atorvastatin
N1002 	Reference T6 MeSH:D000069059	atorvastatin
T7	Pharmacological_substance 171 180	diltiazem
N1003 	Reference T7 MeSH:D004110	diltiazem
T8	Disorder 300 319	acute renal failure
N4 	Reference T8 UMLS:C0022660	acute renal failure
N5 	Reference T8 UMLS:C3854173	acute renal failure
T9	Disorder 333 347	rhabdomyolysis
N6 	Reference T9 UMLS:C0035410	rhabdomyolysis
T10	Pharmacological_substance 474 483	diltiazem
N1004 	Reference T10 MeSH:D004110	diltiazem
T11	Disorder 504 523	atrial fibrillation
N7 	Reference T11 UMLS:C0004238	atrial fibrillation
T12	Pharmacological_substance 574 586	atorvastatin
N1005 	Reference T12 MeSH:D000069059	atorvastatin
T13	Disorder 588 602	Rhabdomyolysis
N8 	Reference T13 UMLS:C0035410	Rhabdomyolysis
T14	Pharmacological_substance 643 706	hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors
T16	Pharmacological_substance 774 786	Atorvastatin
N1006 	Reference T16 MeSH:D000069059	Atorvastatin
T17	Disorder 891 905	hyperlipidemia
N9 	Reference T17 UMLS:C0020473	hyperlipidemia
T18	Disorder 907 921	Rhabdomyolysis
N10 	Reference T18 UMLS:C0035410	Rhabdomyolysis
T19	Pharmacological_substance 966 975	diltiazem
N1007 	Reference T19 MeSH:D004110	diltiazem
T20	Pharmacological_substance 986 1014	HMG-CoA reductase inhibitors
N1008 	Reference T20 MeSH:D019161	HMG-CoA reductase inhibitors
T22	Pharmacological_substance 1124 1136	atorvastatin
N1009 	Reference T22 MeSH:D000069059	atorvastatin
T23	Pharmacological_substance 1141 1150	diltiazem
N1010 	Reference T23 MeSH:D004110	diltiazem
T24	Disorder 1229 1243	rhabdomyolysis
N11 	Reference T24 UMLS:C0035410	rhabdomyolysis
T25	Disorder 1261 1280	acute renal failure
N12 	Reference T25 UMLS:C0022660	acute renal failure
N13 	Reference T25 UMLS:C3854173	acute renal failure
T26	Disorder 1299 1308	hepatitis
N14 	Reference T26 UMLS:C0019158	hepatitis
T27	Pharmacological_substance 1364 1376	atorvastatin
N1011 	Reference T27 MeSH:D000069059	atorvastatin
T28	Pharmacological_substance 1381 1390	diltiazem
N1012 	Reference T28 MeSH:D004110	diltiazem
T29	Pharmacological_substance 1588 1615	HMG-CoA reductase inhibitor
N1013 	Reference T29 MeSH:D019161	HMG-CoA reductase inhibitor
N1014 	Reference T29 MeSH:D019161	HMG-CoA reductase inhibitor
T32	Disorder 1680 1693	muscle injury
N15 	Reference T32 UMLS:C0410256	muscle injury
N16 	Reference T32 UMLS:C1998242	muscle injury
T31	Subject 182 216	A 60-year-old African American man
T15	Combination 20 30	concurrent
T30	Combination 134 150	coadministration
T41	Negation_cue 1062 1064	no
T40	Subject 1565 1577	All patients
T42	Speculation_cue 62 68	report
T45	Combination 712 726	coadministered
T47	Manner_cue 799 805	potent
T49	Combination 1137 1140	and
T50	Coreferring_mention 1100 1118	this adverse event
T33	Pharmacological_substance 732 772	agents that may inhibit their metabolism
T58	Pharmacological_substance 1482 1488	statin
N1015 	Reference T58 MeSH:D019161	statin
T61	Speculation_cue 1624 1630	should
T44	Subject 1166 1173	patient
